Elutia (ELUT) EPS (Weighted Average and Diluted) (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Elutia | 45.79 Mn | 17.31 Mn | 1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -112.59% |
| Dec 31, 2025 | -33.33% |
| Sep 30, 2025 | 53.85% |
| Jun 30, 2025 | -23.81% |
| Mar 31, 2025 | -40.00% |
| Dec 31, 2024 | 54.55% |
| Sep 30, 2024 | 70.80% |
| Jun 30, 2024 | -50.67% |
| Mar 31, 2024 | -36.36% |
| Dec 31, 2023 | 3.51% |
| Sep 30, 2023 | -18.75% |
| Jun 30, 2023 | 2.04% |
| Mar 31, 2023 | -36.11% |
| Dec 31, 2022 | 50.68% |
| Sep 30, 2022 | -5.80% |
| Jun 30, 2022 | -15.00% |
| Mar 31, 2022 | 28.57% |
| Dec 31, 2021 | -3.70% |
| Sep 30, 2021 | -252.17% |
| Jun 30, 2021 | 54.00% |
| Mar 31, 2021 | -102.28% |
| Dec 31, 2020 | 238.95% |
| Sep 30, 2020 | -97.62% |